Financial statements Amber Pharm

Cash flow statement of Amber Pharm

Company age:
Age:
14 y. 8 m. 11 d.
Share capital:
Share capital:
300 000 PLN

Cash inflows of AMBER PHARM

Year
2020
2021
2022
2023
Net cash from operating expenses 439 509,46 312 875,52 1 366 101,66 225 829,22
Net cash flow from investing activities -484 486,58 -86 899,99 -1 741 402,00 -37 695,47
Net cash flow from financial activities -189 065,75 -110 109,38 574 733,85 -168 746,32
Total net cash flow -234 042,87 115 866,15 199 433,51 19 387,43
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.